Atlas Trials

Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease

Clinical trial NCT01449110 · COMPLETED

Trial details

NCT number
NCT01449110
Sponsor
National Research Council, Spain
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiovascular Diseases
Start date
2009-04-01
Primary completion
2010-10-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.